Janet Siliciano
Overview
Explore the profile of Janet Siliciano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Statzu M, Jin W, Fray E, Wong A, Kumar M, Ferrer E, et al.
Nat Microbiol
. 2023 Jan;
8(2):299-308.
PMID: 36690860
Persistence of the human immunodeficiency virus type-1 (HIV-1) latent reservoir in infected individuals remains a problem despite fully suppressive antiretroviral therapy (ART). While reservoir formation begins during acute infection, the...
2.
Turk G, Seiger K, Lian X, Sun W, Parsons E, Gao C, et al.
Ann Intern Med
. 2021 Nov;
175(1):95-100.
PMID: 34781719
Background: A sterilizing cure of HIV-1 infection has been reported in 2 persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous for the...
3.
Wagner C, Hanumanthu V, Talbot Jr C, Abraham R, Hamm D, Gable D, et al.
J Clin Invest
. 2018 Sep;
128(12):5222-5234.
PMID: 30179220
The mechanisms that drive T cell aging are not understood. We report that children and adult telomerase mutation carriers with short telomere length (TL) develop a T cell immunodeficiency that...
4.
Deeks S, Lewin S, Ross A, Ananworanich J, Benkirane M, Cannon P, et al.
Nat Med
. 2016 Jul;
22(8):839-50.
PMID: 27400264
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in...
5.
Yukl S, Boritz E, Busch M, Bentsen C, Chun T, Douek D, et al.
PLoS Pathog
. 2013 May;
9(5):e1003347.
PMID: 23671416
There is intense interest in developing curative interventions for HIV. How such a cure will be quantified and defined is not known. We applied a series of measurements of HIV...
6.
Margolick J, Imteyaz H, Gallant J, Langan S, Dinoso J, Siliciano J, et al.
AIDS
. 2010 Mar;
24(6):932-5.
PMID: 20234195
No abstract available.
7.
Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano R
Trends Mol Med
. 2004 Nov;
10(11):525-31.
PMID: 15519278
HIV-1 can avoid host immune responses and antiretroviral drugs through the latent infection of resting memory CD4(+) T cells. Recently, latent viral genomes have been shown to reside within the...
8.
Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, Siliciano J, et al.
J Virol
. 2004 Jan;
78(4):1718-29.
PMID: 14747537
Human immunodeficiency virus type 1 (HIV-1)-infected individuals who develop drug-resistant virus during antiretroviral therapy may derive benefit from continued treatment for two reasons. First, drug-resistant viruses can retain partial susceptibility...